These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10967368)

  • 1. Deliberate self poisoning with antidepressant drugs: a comparison of the relative hospital costs of cases of overdose of tricyclics with those of selective-serotonin re-uptake inhibitors.
    Ramchandani P; Murray B; Hawton K; House A
    J Affect Disord; 2000 Nov; 60(2):97-100. PubMed ID: 10967368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of antidepressant overdose: a preliminary study.
    Kapur N; House A; Creed F; Feldman E; Friedman T; Guthrie E
    Br J Gen Pract; 1999 Sep; 49(446):733-4. PubMed ID: 10756618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSRIs versus tricyclics.
    Rubinsztien JS; Michael A
    Br J Psychiatry; 1996 Jul; 169(1):113-4. PubMed ID: 8818380
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal toxicity associated with antidepressant use in primary care.
    Mason J; Freemantle N; Eccles M
    Br J Gen Pract; 2000 May; 50(454):366-70. PubMed ID: 10897532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The toxicity of antidepressant poisoning: is it changing? A comparative study of cyclic and newer serotonin-specific antidepressants.
    Graudins A; Dowsett RP; Liddle C
    Emerg Med (Fremantle); 2002 Dec; 14(4):440-6. PubMed ID: 12534489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.
    Whyte IM; Dawson AH; Buckley NA
    QJM; 2003 May; 96(5):369-74. PubMed ID: 12702786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.
    Isbister GK; Bowe SJ; Dawson A; Whyte IM
    J Toxicol Clin Toxicol; 2004; 42(3):277-85. PubMed ID: 15362595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
    Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
    Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are SSRIs a cost-effective alternative to tricyclics?
    Hotopf M; Lewis G; Normand C
    Br J Psychiatry; 1996 Apr; 168(4):404-9. PubMed ID: 8730935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdoses.
    Revicki DA; Palmer CS; Phillips SD; Reblando JA; Heiligenstein JH; Brent J; Kulig K
    Pharmacoeconomics; 1997 Jan; 11(1):48-55. PubMed ID: 10165526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of antidepressant overdose.
    D'Mello DA; Finkbeiner DS; Kocher KN
    Gen Hosp Psychiatry; 1995 Nov; 17(6):454-5. PubMed ID: 8714807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between mortality from suicide in England and antidepressant prescribing: an ecological study.
    Morgan OW; Griffiths C; Majeed A
    BMC Public Health; 2004 Dec; 4():63. PubMed ID: 15613234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicidal antidepressant overdoses: a comparative analysis by antidepressant type.
    White N; Litovitz T; Clancy C
    J Med Toxicol; 2008 Dec; 4(4):238-50. PubMed ID: 19031375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
    Bateman DN; Chick J; Good AM; Kelly CA; Masterton G
    Eur J Clin Pharmacol; 2004 May; 60(3):221-4. PubMed ID: 15083251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-poisonings with tricyclic antidepressants and selective serotonin reuptake inhibitors in Tehran, Iran.
    Naderi-Heiden A; Shadnia S; Salimi AR; Naderi A; Naderi MM; Schmid D; Gleiss A; Kasper S; Frey R
    World J Biol Psychiatry; 2009; 10(4):302-12. PubMed ID: 19921972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the use of SSRIs reduce medical care utilization and expenditures?
    Chung S
    J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deliberate self-harm and antidepressant drugs. Investigation of a possible link.
    Donovan S; Clayton A; Beeharry M; Jones S; Kirk C; Waters K; Gardner D; Faulding J; Madeley R
    Br J Psychiatry; 2000 Dec; 177():551-6. PubMed ID: 11102331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide.
    Freemantle N; House A; Song F; Mason JM; Sheldon TA
    BMJ; 1994 Jul; 309(6949):249-53. PubMed ID: 7832842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.